Company Filing History:
2 out of 16 
1 out of 832,912 Years Active: 2001-2004
Title: Innovations in Vascular Treatment by Inventor Dave Delaney
Introduction
Dave Delaney is a notable inventor based in Menlo Park, California, recognized for his contributions to medical technology. He holds three patents that focus on catheter devices and methods aimed at treating vascular occlusions. His work is significant in enhancing fluid flow in obstructed vascular sites, which is crucial for patients suffering from various vascular diseases.
Latest Patents
Delaney's latest patents include innovative catheter devices designed for the treatment of calcified vascular occlusions. These devices feature multiple lumens, each serving a specific purpose. The first lumen delivers an acidic dissolution solution, the second lumen provides a buffer solution, and the third lumen is responsible for removing fluid from the vascular site. This design allows for simultaneous flushing of the vascular site, enhancing fluid flow while minimizing contact with harmful acidic solutions. His methods and devices are particularly beneficial for treating peripheral and coronary vascular diseases.
Career Highlights
Throughout his career, Delaney has worked with various companies, including Corazon Technologies, Inc. His experience in the medical technology field has allowed him to develop groundbreaking solutions that address critical health issues related to vascular occlusions. His patents reflect a deep understanding of the complexities involved in vascular treatments and demonstrate his commitment to improving patient outcomes.
Collaborations
Delaney has collaborated with notable professionals in the field, including Brent Richard Constantz and Peter K Johansson. These partnerships have likely contributed to the innovative nature of his work and the successful development of his patented technologies.
Conclusion
Dave Delaney's contributions to the field of vascular treatment through his patented innovations highlight his role as a significant inventor in medical technology. His work continues to impact the treatment of vascular diseases, improving the quality of care for patients worldwide.